NO20022103L - Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist - Google Patents

Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist

Info

Publication number: NO20022103L
Authority: NO; Norway
Prior art keywords: beta; andrenoreceptor; agonist; receptor antagonist; combination including
Prior art date: 1999-11-03

Application number

NO20022103A

Other languages

English (en)

Other versions

NO20022103D0 (no

Inventor

Jan Trofast

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-03

Filing date

2002-05-02

Publication date

2002-05-02

2002-05-02 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-05-02 Publication of NO20022103L publication Critical patent/NO20022103L/no

2002-05-02 Publication of NO20022103D0 publication Critical patent/NO20022103D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20022103A 1999-11-03 2002-05-02 Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist NO20022103D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9903995A SE9903995D0 (sv)	1999-11-03	1999-11-03	New combination
PCT/SE2000/002115 WO2001032163A1 (en)	1999-11-03	2000-10-27	NEW COMBINATION COMPRISING A BETA 2 (β)2 ADRENO RECEPTOR AGONIST AND A LENKOTRIENE RECEPTOR ANTAGONIST

Publications (2)

Publication Number	Publication Date
NO20022103L true NO20022103L (no)	2002-05-02
NO20022103D0 NO20022103D0 (no)	2002-05-02

Family

ID=20417605

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022103A NO20022103D0 (no)	1999-11-03	2002-05-02	Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist

Country Status (13)

Country	Link
EP (1)	EP1242065A1 (no)
JP (1)	JP2003513037A (no)
KR (1)	KR20020050254A (no)
CN (1)	CN1387431A (no)
AU (2)	AU1321401A (no)
BR (1)	BR0015172A (no)
CA (1)	CA2388657A1 (no)
IL (1)	IL149365A0 (no)
MX (1)	MXPA02004334A (no)
NO (1)	NO20022103D0 (no)
SE (1)	SE9903995D0 (no)
WO (2)	WO2001032163A1 (no)
ZA (1)	ZA200203178B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
PE20050130A1 (es) *	2002-08-09	2005-03-29	Novartis Ag	Compuestos organicos
GB0312148D0 (en)	2003-05-28	2003-07-02	Aventis Pharma Ltd	Stabilized pharmaceutical products
GB0315889D0 (en)	2003-07-08	2003-08-13	Aventis Pharma Ltd	Stable pharmaceutical products
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
JP2007531743A (ja) *	2004-04-05	2007-11-08	セプラコアインコーポレーテッド	他の薬剤と組合せた（ｒ，ｒ）−ホルモテロール
ES2245612B1 (es) *	2004-06-29	2007-08-16	Universidad De Barcelona	Nuevo uso terapeutico del formoterol.
HUE027076T2 (en) *	2005-03-16	2016-08-29	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
CA2838435A1 (en) *	2011-06-06	2012-12-13	Chiesi Farmaceutici S.P.A.	Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
TR201907092T4 (tr) *	2012-12-05	2019-06-21	Chiesi Farm Spa	Fosfodiesteraz inhibitörleri olarak 1-fenil-2-piridinil alkil alkol türevleri.
JP5846185B2 (ja)	2013-11-21	2016-01-20	大日本印刷株式会社	貫通電極基板及び貫通電極基板を用いた半導体装置
PT109030B (pt) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	Preparação de partículas inaláveis de zafirlucaste

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9604752D0 (sv) *	1996-12-20	1996-12-20	Astra Ab	Formulation and use
WO1998039970A1 (en) *	1997-03-13	1998-09-17	Merck & Co., Inc.	Quinoline leukotriene antagonists
SE9704644D0 (sv) *	1997-12-12	1997-12-12	Astra Ab	New use

1999
- 1999-11-03 SE SE9903995A patent/SE9903995D0/xx unknown
2000
- 2000-10-27 WO PCT/SE2000/002115 patent/WO2001032163A1/en not_active Ceased
- 2000-10-27 CN CN00815363A patent/CN1387431A/zh active Pending
- 2000-10-27 AU AU13214/01A patent/AU1321401A/en not_active Abandoned
- 2000-10-27 IL IL14936500A patent/IL149365A0/xx unknown
- 2000-10-27 WO PCT/SE2000/002116 patent/WO2001032166A1/en not_active Ceased
- 2000-10-27 EP EP00975117A patent/EP1242065A1/en not_active Withdrawn
- 2000-10-27 MX MXPA02004334A patent/MXPA02004334A/es unknown
- 2000-10-27 AU AU16526/01A patent/AU1652601A/en not_active Abandoned
- 2000-10-27 KR KR1020027005683A patent/KR20020050254A/ko not_active Withdrawn
- 2000-10-27 CA CA002388657A patent/CA2388657A1/en not_active Abandoned
- 2000-10-27 JP JP2001534368A patent/JP2003513037A/ja active Pending
- 2000-10-27 BR BR0015172-6A patent/BR0015172A/pt not_active Application Discontinuation
2002
- 2002-04-22 ZA ZA200203178A patent/ZA200203178B/xx unknown
- 2002-05-02 NO NO20022103A patent/NO20022103D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200203178B (en)	2003-07-22
MXPA02004334A (es)	2002-11-07
IL149365A0 (en)	2002-11-10
EP1242065A1 (en)	2002-09-25
WO2001032163A1 (en)	2001-05-10
AU1321401A (en)	2001-05-14
SE9903995D0 (sv)	1999-11-03
CA2388657A1 (en)	2001-05-10
BR0015172A (pt)	2002-06-18
AU1652601A (en)	2001-05-14
JP2003513037A (ja)	2003-04-08
KR20020050254A (ko)	2002-06-26
NO20022103D0 (no)	2002-05-02
WO2001032166A1 (en)	2001-05-10
CN1387431A (zh)	2002-12-25

Publication	Publication Date	Title
NO20006220D0 (no)	2000-12-07	<beta>2-adrenergistiske reseptoragonister
NO20004215D0 (no)	2000-08-23	Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav
DE69800895D1 (de)	2001-07-19	Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)
NO20015359L (no)	2001-11-02	Nye medikamentblandinger basert på anti-cholinergisk effektive forbindelser og <beta>-mimetika
NO960081L (no)	1996-07-10	Östrogen-agonist/antagonister
DK1189916T3 (da)	2004-03-22	N-pyrazol A 2A-receptoragonister
DE69905248D1 (de)	2003-03-13	Neuropeptid y5-rezeptorantagonisten
FR10C0006I2 (fr)	2011-04-01	Agonistes du recepteur beta 2-adrenergique
ATE280157T1 (de)	2004-11-15	4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO20022103D0 (no)	2002-05-02	Ny kombinasjon innbefattende en beta 2 (<beta>)2 andrenore- septoragonist og leukotrienreseptorantagonist
NO20030098L (no)	2003-01-09	<Beta>3 adrenergiske agonister
EP1229910A4 (en)	2003-10-01	integrin
AU775774C (en)	2005-05-19	Peroxisome proliferator-activated receptor agonist
NO20010804L (no)	2001-04-11	Muskariniske agonister og antagonister
ATE416173T1 (de)	2008-12-15	1-(3 -heteroarylpropyl- oder -prop -2-enyl) -4- benzylpiperidine als nmda-rezeptor-antagonisten
MA26890A1 (fr)	2004-12-20	Metabolites agonistes/ antagonistes d'oestrogenes
NO20004503L (no)	2000-10-10	Vitronectin-reseptor-antagonister
ID26086A (id)	2000-11-23	Ligan-ligan reseptor 5ht1 azabisiklik
IL138576A0 (en)	2001-10-31	A novel interleukin-1 receptor antagonist and uses thereof
DK1146874T3 (da)	2005-01-31	Vitronectinreceptoragonist
IL137428A0 (en)	2001-07-24	Estrogen agonists and antagonists for multiple indications
NO20013978L (no)	2001-08-15	Dopamin D1 reseptor agonist forbindelser
NO20035319D0 (no)	2003-11-28	En G-proteinkoblet reseptor og anvendelse derav
SE0003995D0 (sv)	2000-11-01	Receptoragonister och antagonister
DE69830671D1 (de)	2005-07-28	Integrin-rezeptor-antagonisten

Legal Events

Date	Code	Title	Description
2004-10-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application